春立医疗2月9日获融资买入524.38万元，融资余额4852.98万元

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Spring Medical, indicating a slight decline in stock price and notable financing activities on February 9 [1] - On February 9, Spring Medical's stock price fell by 0.35%, with a trading volume of 34.99 million yuan. The financing buy-in amounted to 5.24 million yuan, while the financing repayment was 3.77 million yuan, resulting in a net financing buy of 1.48 million yuan [1] - As of February 9, the total financing and securities lending balance for Spring Medical reached 48.55 million yuan, with the financing balance accounting for 0.73% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2] - The company's main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems. Its products are exported to various regions, including Asia, South America, Africa, Oceania, and Europe [2] - For the period from January to September 2025, Spring Medical reported a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, reflecting a significant increase of 213.21% [2] Group 3 - Since its A-share listing, Spring Medical has distributed a total of 440 million yuan in dividends, with 390 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders for Spring Medical increased by 4.12% to 6,164, while the average circulating shares per person decreased by 3.95% to 46,906 shares [2][3] - Among the top ten circulating shareholders, new entrants include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed A, holding 2.96 million shares and 2.83 million shares, respectively [3]